Publications for Karen P. Seiter karen_seiter@nymc.edu
Lancet, J., Uy, G., Cortes, J., Newell, L., Lin, T., Ritchie, E., . . . Seiter K. (2016). Cpx-351 treatment of previously untreated older AMI patients with high risk AMI markedly increases the response rate over 7+3 in patients with FLT3 mutations. Haematologica, 101(Suppl 1), 186. This material can be found here.
Linder, K., Gandhiraj, D., Hanmantgad, M., Seiter, K., & Liu, D. (2016). Complete remission after single agent blinatumomab in a patient with pre-B acute lymphoid leukemia relapsed and refractory to three prior regimens: HyperCVAD, high dose cytarabine mitoxantrone and CLAG. Experimental Hematology & Oncology, 5, 20. doi:10.1186/s40164-016-0051-4
Mamorska-Dyga, A., Wu, J., Khattar, P., Ronny, F. M., Islam, H., Seiter, K., & Liu, D. (2016). Acute promyelocytic leukemia co-existing with JAK2 V617F positive myeloproliferative neoplasm: A case report. Stem Cell Investigation, 3, 8. doi:10.21037/sci.2016.03.02
Martinelli, G., Pappayannidis, C., Yee, K., Vey, N., Drummond, M., Kelly, K., . . . Seiter, K. (2016). Phase 1B results of idasanutlin plus cytarabine (ARA-C) in acute myeloid leukemia (AML) patients (PTS). Haematologica, 101(Suppl 1), 187.
Seiter, K., & Mamorska-Dyga, A. (2015). Obinutuzumab treatment in the elderly patient with chronic lymphocytic leukemia. Clinical Interventions in Aging, 10, 951-961. doi:10.2147/CIA.S69278
Lau, A., & Seiter, K. (2014). Second-line therapy for patients with chronic myeloid leukemia resistant to first-line imatinib. Clinical Lymphoma, Myeloma & Leukemia, 14(3), 186-196. doi:10.1016/j.clml.2013.11.002
Lamanna, N., Heffner, L. T., Kalaycio, M., Schiller, G., Coutre, S., Moore, J., . . . Seiter, K. (2013). Treatment of adults with acute lymphoblastic leukemia: Do the specifics of the regimen matter. Cancer, 119(6), 1186-1194. doi:10.1002/cncr.27901
O'Brien, S., Schiller, G., Lister, J., Damon, L., Goldberg, S., Aulitzky, W., . . . Seiter, K. (2013). High-dose vincristine sulfate liposome injection for advanced, relapsed, and refractory adult Philadelphia chromosome-negative acute lymphoblastic leukemia. Journal of Clinical Oncology, 31(6), 676-683. doi:10.1200/JCO.2012.46.2309
Seiter, K. (2013). Myelodysplasia: New approaches. Current Treatment Options in Oncology, 14(2), 156-169. doi:10.1007/s11864-013-0224-x
